Supports tissue repair and recovery May contribute to healthy tendons, ligaments, and muscles through structural integrity support
FGF15/19 regulates hepatic glucose metabolism by inhibiting the CREB-PGC-1 pathway
The only published human data are from 12 patients with interstitial cystitis (2024) and 2 healthy subjects (2026)
It should be noted that a significant portion of BPC-157 studies originate from a limited number of laboratories, primarily based in Croatia
This is when individuals often feel confident that the treatment is working
BPC-157 vs Physical Therapy: PT is essential, BPC-157 accelerates it Use both together for best results BPC-157 enables more aggressive PT BPC-157 vs NSAIDs: NSAIDs: Reduce pain, slow healing BPC-157: Reduce pain, accelerate healing BPC-157 protects against NSAID damage BPC-157 vs Corticosteroid injections: Steroids: Mask pain, weaken tissue long-term BPC-157: Heal tissue, strengthen long-term BPC-157 is safer for repeated use BPC-157 vs Surgery: Try BPC-157 first for most injuries May avoid surgery for moderate damage Use post-surgery to accelerate recovery For comparison with other performance enhancers, read peptides vs SARMs
